Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 June 2023 | Story Dr Nokuthula Tlalajoe-Mokhatla | Photo Supplied
Dr Nokuthula Tlalajoe-Mokhatla
Dr Nokuthula Tlalajoe-Mokhatla, Academic Head and Senior Lecturer at the Division of Student Learning and Development.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Dr Nokuthula Tlalajoe-Mokhatla, Academic Head and Senior Lecturer at the Division of Student Learning and Development, shares her UFS journey:

Q: Year of graduation from the UFS:

A: I graduated in 2010, 2011, 2013, and 2021 (virtual graduation).

Q: Qualification obtained from the UFS:
A: BSc Biochemistry and Microbiology, BSc Honours Biochemistry, MSc Biochemistry (Cum Laude), PhD in Health Professions Education

Q: Date of joining the UFS as a staff member:
A: I joined as an official staff member on 18 January 2016; however, I have been in the HR system since my third year (2009) when I was appointed as a Laboratory Assistant.

Q: Initial job title and current job title:

A: In the context of point 3, I would safely say I moved from Laboratory Assistant, to Demonstrator, to Lecturer, and now Academic Head of the division and Senior Lecturer.

Q: How did the UFS prepare you for the professional world?

A: Every human being can be taught a skill, be it a scientist, health professional, or accountant. However, how their soft skills complement or lack to complement the core knowledge and application will set that individual apart. That being said, I have utilised the vast opportunities that are always accessible to enhance one's development with regard to lifelong learning skills. My biggest gain was the Engaged Leadership Programme (middle management level), which I completed in 32 weeks and obtained a distinction. That type of training set me in a position that could easily have played a role in me being able to progress further in the professional world.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: The outlook is so different when you are a staff member. I am enjoying the world of being a staff member more. This is due to my struggles as a student – a story for another day. The perks and benefits are more as a staff member, and your world gets bigger and bigger. Networking with like-minded people and contributing to day-to-day activities is mind-blowing for me.

Q: Any additional comments about your experience?
A: I appreciate the support systems in our setting; it comes in handy when we doubt ourselves and think we are not enough or adequate. What I do appreciate is the opportunities that are accessible, and with the help we have in place, it brings a sense of ease to know you can equally access it.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept